DNA Diagnostic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the DNA diagnostic market looks promising with opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The global DNA diagnostic market is expected to grow with a CAGR of 9%-12% from 2020 to 2025. The major drivers for this market are continuous product modifications, increased preference for efficient diagnostic platforms, and increased research & development activities.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global DNA diagnostic market report, please download the report brochure.
In this market, instruments is the largest product of DNA diagnostic, whereas infectious disease is the largest application. Growth in various segments of the DNA diagnostic market are given below:
The study includes trends and forecast for the global DNA diagnostic market by product, technology, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Reagents
Service & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Microarray Based
PCR (Polymerase Chain Reaction) Based
In-situ Hybridization
NGS (Next Generation Sequencing) DNA Diagnosis
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pre-Natal DNA Carrier Screening
Pre-Implantation Diagnosis
Newborn Genetic Screening
Infectious Disease Diagnostics
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the DNA diagnostics model companies profiled in this report include GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen.
Lucintel forecasts that instruments will remain the largest product segment over the forecast period due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.
Within this market, infectious disease diagnostics will remain the largest application segment over the forecast period due to the increasing prevelance of infectious diseases, advantages of DNA testing in infectious diseases for early detection, and technological advancement for diagnostic application.
North America will remain the largest region over the forecast period due to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and high prevalence of chronic diseases in the region.
Features of the Global DNA Diagnostic Market
Market Size Estimates: Global DNA diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global DNA diagnostic market size by various segments, such as product, technology, and application in terms of value.Regional Analysis: Global DNA diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, and region for the global DNA diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global DNA diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global DNA diagnostic market by product (instruments, reagents, and service & software), technology (microarray based, PCR based, in-situ hybridization, and NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global DNA diagnostic market?
Q.5 What are the business risks and threats to the global DNA diagnostic market?
Q.6 What are the emerging trends in this DNA diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this DNA diagnostic market?
Q.8 What are the new developments in this DNA diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this DNA diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this DNA diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global DNA diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Type (Instruments, Reagents, and Service & Software), Technology (Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis), and Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the DNA diagnostic market looks promising with opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The global DNA diagnostic market is expected to grow with a CAGR of 9%-12% from 2020 to 2025. The major drivers for this market are continuous product modifications, increased preference for efficient diagnostic platforms, and increased research & development activities.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global DNA diagnostic market report, please download the report brochure.
In this market, instruments is the largest product of DNA diagnostic, whereas infectious disease is the largest application. Growth in various segments of the DNA diagnostic market are given below:
The study includes trends and forecast for the global DNA diagnostic market by product, technology, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Reagents
Service & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Microarray Based
PCR (Polymerase Chain Reaction) Based
In-situ Hybridization
NGS (Next Generation Sequencing) DNA Diagnosis
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pre-Natal DNA Carrier Screening
Pre-Implantation Diagnosis
Newborn Genetic Screening
Infectious Disease Diagnostics
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the DNA diagnostics model companies profiled in this report include GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen.
Lucintel forecasts that instruments will remain the largest product segment over the forecast period due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.
Within this market, infectious disease diagnostics will remain the largest application segment over the forecast period due to the increasing prevelance of infectious diseases, advantages of DNA testing in infectious diseases for early detection, and technological advancement for diagnostic application.
North America will remain the largest region over the forecast period due to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and high prevalence of chronic diseases in the region.
Features of the Global DNA Diagnostic Market
Market Size Estimates: Global DNA diagnostic market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global DNA diagnostic market size by various segments, such as product, technology, and application in terms of value.Regional Analysis: Global DNA diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, technology, application, and region for the global DNA diagnostic market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global DNA diagnostic market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global DNA diagnostic market by product (instruments, reagents, and service & software), technology (microarray based, PCR based, in-situ hybridization, and NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global DNA diagnostic market?
Q.5 What are the business risks and threats to the global DNA diagnostic market?
Q.6 What are the emerging trends in this DNA diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this DNA diagnostic market?
Q.8 What are the new developments in this DNA diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this DNA diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this DNA diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global DNA diagnostic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Type (Instruments, Reagents, and Service & Software), Technology (Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis), and Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global DNA Diagnostic Market Trends and Forecast
3.3: Global DNA Diagnostic Market by Product
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Service & Software
3.4: Global DNA Diagnostic Market by Technology
3.4.1: Microarray Based
3.4.2: PCR Based
3.4.3: In-situ Hybridization
3.4.4: NGS DNA Diagnosis
3.5: Global DNA Diagnostic Market by Application
3.5.1: Pre-natal DNA Carrier Screening
3.5.2: Pre-implantation Diagnosis
3.5.3: Newborn Genetic Screening
3.5.4: Infectious Disease Diagnostics
3.5.5: Oncology Diagnostics & Histopathology
3.5.6: Identity Diagnostics & Forensics
3.5.7: Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global DNA Diagnostic Market by Region
4.2: North American DNA Diagnostic Market
4.2.1: Market by Product: Instruments, Reagents, and Service & Software
4.2.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.2.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.2.4: The United States DNA Diagnostic Market
4.2.5: The Canadian DNA Diagnostic Market
4.2.6: The Mexican DNA Diagnostic Market
4.3: European DNA Diagnostic Market
4.3.1: Market by Product: Instruments, Reagents, and Service & Software
4.3.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.3.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.3.4: The United Kingdom DNA Diagnostic Market
4.3.5: The Spanish DNA Diagnostic Market
4.3.6: The German DNA Diagnostic Market
4.3.7: The French DNA Diagnostic Market
4.4: APAC DNA Diagnostic Market
4.4.1: Market by Product: Instruments, Reagents, and Service & Software
4.4.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.4.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.4.4: The Chinese DNA Diagnostic Market
4.4.5: The Indian DNA Diagnostic Market
4.4.6: The Japanese DNA Diagnostic Market
4.5: ROW DNA Diagnostic Market
4.5.1: Market by Product: Instruments, Reagents, and Service & Software
4.5.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.5.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.5.4: Brazilian DNA Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global DNA Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global DNA Diagnostic Market by Technology
7.1.3: Growth Opportunities for the Global DNA Diagnostic Market by Application
7.1.4: Growth Opportunities for the Global DNA Diagnostic Market by Region
7.2: Emerging Trends in the Global DNA Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global DNA Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global DNA Diagnostics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: GE Healthcare
8.2: Abbott Laboratories
8.3: Beckman Coulter Inc
8.4: Bio-Rad Laboratories
8.5: Therm Fisher Scientific
8.6: Illumina Inc.
8.7: Cephide Inc.
8.8: Siemens Healthcare
8.9: Roche Diagnostics
8.10: Hologic
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global DNA Diagnostic Market Trends and Forecast
3.3: Global DNA Diagnostic Market by Product
3.3.1: Instruments
3.3.2: Reagents
3.3.3: Service & Software
3.4: Global DNA Diagnostic Market by Technology
3.4.1: Microarray Based
3.4.2: PCR Based
3.4.3: In-situ Hybridization
3.4.4: NGS DNA Diagnosis
3.5: Global DNA Diagnostic Market by Application
3.5.1: Pre-natal DNA Carrier Screening
3.5.2: Pre-implantation Diagnosis
3.5.3: Newborn Genetic Screening
3.5.4: Infectious Disease Diagnostics
3.5.5: Oncology Diagnostics & Histopathology
3.5.6: Identity Diagnostics & Forensics
3.5.7: Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global DNA Diagnostic Market by Region
4.2: North American DNA Diagnostic Market
4.2.1: Market by Product: Instruments, Reagents, and Service & Software
4.2.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.2.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.2.4: The United States DNA Diagnostic Market
4.2.5: The Canadian DNA Diagnostic Market
4.2.6: The Mexican DNA Diagnostic Market
4.3: European DNA Diagnostic Market
4.3.1: Market by Product: Instruments, Reagents, and Service & Software
4.3.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.3.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.3.4: The United Kingdom DNA Diagnostic Market
4.3.5: The Spanish DNA Diagnostic Market
4.3.6: The German DNA Diagnostic Market
4.3.7: The French DNA Diagnostic Market
4.4: APAC DNA Diagnostic Market
4.4.1: Market by Product: Instruments, Reagents, and Service & Software
4.4.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.4.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.4.4: The Chinese DNA Diagnostic Market
4.4.5: The Indian DNA Diagnostic Market
4.4.6: The Japanese DNA Diagnostic Market
4.5: ROW DNA Diagnostic Market
4.5.1: Market by Product: Instruments, Reagents, and Service & Software
4.5.2: Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.5.3: Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.5.4: Brazilian DNA Diagnostic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global DNA Diagnostic Market by Product
7.1.2: Growth Opportunities for the Global DNA Diagnostic Market by Technology
7.1.3: Growth Opportunities for the Global DNA Diagnostic Market by Application
7.1.4: Growth Opportunities for the Global DNA Diagnostic Market by Region
7.2: Emerging Trends in the Global DNA Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global DNA Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global DNA Diagnostics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: GE Healthcare
8.2: Abbott Laboratories
8.3: Beckman Coulter Inc
8.4: Bio-Rad Laboratories
8.5: Therm Fisher Scientific
8.6: Illumina Inc.
8.7: Cephide Inc.
8.8: Siemens Healthcare
8.9: Roche Diagnostics
8.10: Hologic
